These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 5288250)

  • 21. Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism.
    Meyer UA; Strand LJ; Doss M; Rees AC; Marver HS
    N Engl J Med; 1972 Jun; 286(24):1277-82. PubMed ID: 5024458
    [No Abstract]   [Full Text] [Related]  

  • 22. Acute intermittent porphyria. Increased ALA-synthetase activity during an acute attack.
    Sweeney VP; Pathak MA; Asbury AK
    Brain; 1970; 93(2):369-80. PubMed ID: 5422412
    [No Abstract]   [Full Text] [Related]  

  • 23. Delta-amino-levulinic acid, porphobilinogen, and porphyrin excretion throughout pregnancy in a patient with acute intermittent porphyria with "passive porphyria" in the infant.
    JAMES GW; RUDOLPH SG; ABBOTT LD
    J Lab Clin Med; 1961 Sep; 58():437-44. PubMed ID: 13789298
    [No Abstract]   [Full Text] [Related]  

  • 24. Effect of pyridoxine deficiency on porphyrin precursor excretion in acute intermittent porphyria.
    Elder TD; Mengel CE
    Am J Med; 1966 Sep; 41(3):369-74. PubMed ID: 5914112
    [No Abstract]   [Full Text] [Related]  

  • 25. Hematin treatment of acute porphyria. Early remission of an almost fatal relapse.
    Peterson A; Bossenmaier I; Cardinal R; Watson CJ
    JAMA; 1976 Feb; 235(5):520-2. PubMed ID: 946099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hormonal oral contraceptives, urinary porphyrin excretion and porphyrias.
    Gross U; Honcamp M; Daume E; Frank M; Düsterberg B; Doss MO
    Horm Metab Res; 1995 Aug; 27(8):379-83. PubMed ID: 7590628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biochemical effects of chloroquine therapy in porphyria cutanea tarda.
    Vogler WR; Galambos JT; Olansky S
    Am J Med; 1970 Sep; 49(3):316-21. PubMed ID: 5455563
    [No Abstract]   [Full Text] [Related]  

  • 28. [Quantitative determination of delta-aminolevulinic acid and porphobilinogen in urine, using ion exchange chromatography columns].
    Doss M; Schmidt A
    Z Klin Chem Klin Biochem; 1971 Mar; 9(2):99-102. PubMed ID: 5573981
    [No Abstract]   [Full Text] [Related]  

  • 29. Diagnosis and treatment of the porphyrias.
    Goldberg A
    Proc R Soc Med; 1968 Feb; 61(2):193-6. PubMed ID: 5637835
    [No Abstract]   [Full Text] [Related]  

  • 30. [Normal values for the concentrations of porphyrins and porphyrin precursors].
    Goreczky L; Róth I; Breckner M
    Z Klin Chem Klin Biochem; 1968 Nov; 6(6):489-92. PubMed ID: 5723227
    [No Abstract]   [Full Text] [Related]  

  • 31. Acute intermittent porphyria in Poland.
    Darocha T; Gregor A
    S Afr Med J; 1971 Sep; ():204-17. PubMed ID: 5150281
    [No Abstract]   [Full Text] [Related]  

  • 32. Stability of delta-aminolevulinic acid and porphobilinogen in urine under varying conditions.
    Bossenmaier I; Cardinal R
    Clin Chem; 1968 Jul; 14(7):610-4. PubMed ID: 5663456
    [No Abstract]   [Full Text] [Related]  

  • 33. [Hypertension and tachycardia in acute intermittent porphyria].
    Schley G; Bock KD; Hocevar V; Merguet P; Rausch-Stroomann JG; Schröder E; Schümann HJ
    Klin Wochenschr; 1970 Jan; 48(1):36-42. PubMed ID: 5522113
    [No Abstract]   [Full Text] [Related]  

  • 34. Plasma porphyrin concentrations in porphyria cutanea tarda.
    Moore MR; Thompson GG; Allen BR; Hunter JA; Parker S
    Clin Sci Mol Med; 1973 Nov; 45(5):711-4. PubMed ID: 4759516
    [No Abstract]   [Full Text] [Related]  

  • 35. Conventional and preparative electrophoretic separation of some urinary porphyrins and porphyrin precursors.
    Fischl J; Eichhorn F; Ruttenberg A; Major C
    Clin Chem; 1970 Apr; 16(4):331-4. PubMed ID: 5442210
    [No Abstract]   [Full Text] [Related]  

  • 36. Porphyria induced in the rabbit by diethyl 1,4-dihydro-2,4,6-trimethylpyridine-3,5-dicarboxylate. I. Excretion of 5-aminolaevulic acid, porphobilinogen, coproporphyrin and protoporphyrin.
    HAEGER-ARONSEN B
    Acta Pharmacol Toxicol (Copenh); 1961; 18():165-9. PubMed ID: 13903511
    [No Abstract]   [Full Text] [Related]  

  • 37. [Porphyrins and their precursors in the urine of patients with suspected porphyria; a 16-year experience].
    Zawirska B; Kwiatkowska W; Nowojska A
    Pol Tyg Lek; 1985 Jan; 40(4):97-100. PubMed ID: 3983004
    [No Abstract]   [Full Text] [Related]  

  • 38. FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. I. THE EFFECT OF DIET.
    WELLAND FH; HELLMAN ES; GADDIS EM; COLLINS G; HUNTER GW; TSCHUDY DP
    Metabolism; 1964 Mar; 13():232-50. PubMed ID: 14127691
    [No Abstract]   [Full Text] [Related]  

  • 39. FACTORS AFFECTING THE EXCRETION OF PORPHYRIN PRECURSORS BY PATIENTS WITH ACUTE INTERMITTENT PORPHYRIA. II. THE EFFECT OF ETHINYL ESTRADIOL.
    WELLAND FH; HELLMAN ES; COLLINS A; HUNTER GW; TSCHUDY DP
    Metabolism; 1964 Mar; 13():251-8. PubMed ID: 14127692
    [No Abstract]   [Full Text] [Related]  

  • 40. [Appraisal of the methods of expressing lead concentrations and porphyrin precursors in the urine].
    Iliescu S; Stavri G; Freund S; Vasilíu A
    Rev Med Chir Soc Med Nat Iasi; 1969; 73(4):955-60. PubMed ID: 5370591
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.